Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob Schachter

Showing results (81-90 of 153) with videos related to

Pageof 16
Sort By:
Oncotarget|January 29, 2016
Use of HLA peptidomics and whole exome sequencing to identify human immunogenic neo-antigensShelly Kalaora, Eilon Barnea, Efrat Merhavi-Shoham, et al.
Journal for Immunotherapy of Cancer|May 15, 2021
Comparison of non-myeloablative lymphodepleting preconditioning regimens in patients undergoing adoptive T cell therapyAbraham Nissani, Shaked Lev-Ari, Tomer Meirson, et al.
Oncoimmunology|May 7, 2020
Immune co-culture cell microarray - a feasible tool for high-throughput functional investigation of lymphocyte-cancer interactionsErez Nissim Baruch, Rona Ortenberg, Camila Avivi, et al.
Anticancer Research|April 1, 2009
Preclinical evaluation of adoptive cell therapy for patients with metastatic renal cell carcinomaGal Markel, Tali Cohen-Sinai, Michal J Besser, et al.
Neurology|August 31, 2023
Incidence and Outcome of Neurologic Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors in Patients With MelanomaJack Pepys, Ronen Stoff, Roni Ramon-Gonen, et al.
Melanoma Research|February 24, 2021
The efficacy of immunotherapy for in-transit metastases of melanoma: an analysis of randomized controlled trialsRoger Olofsson Bagge, Lars Ny, Paolo A Ascierto, et al.
Plos One|March 2, 2013
Nicotinamide inhibits vasculogenic mimicry, an alternative vascularization pathway observed in highly aggressive melanomaOrit Itzhaki, Eyal Greenberg, Bruria Shalmon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 24, 2006
Inhibition of human tumor-infiltrating lymphocyte effector functions by the homophilic carcinoembryonic cell adhesion molecule 1 interactionsGal Markel, Rachel Seidman, Noam Stern, et al.
Molecular Cancer Therapeutics|April 3, 2012
Novel immunotherapy for malignant melanoma with a monoclonal antibody that blocks CEACAM1 homophilic interactionsRona Ortenberg, Yair Sapir, Lee Raz, et al.
Plos One|May 5, 2011
Regulation of cancer aggressive features in melanoma cells by microRNAsEyal Greenberg, Liat Hershkovitz, Orit Itzhaki, et al.
Pageof 16

Showing results (81-90 of 153) with videos related to

Sort By:
Pageof 16
Oncotarget|January 29, 2016
Use of HLA peptidomics and whole exome sequencing to identify human immunogenic neo-antigensShelly Kalaora, Eilon Barnea, Efrat Merhavi-Shoham, et al.
Journal for Immunotherapy of Cancer|May 15, 2021
Comparison of non-myeloablative lymphodepleting preconditioning regimens in patients undergoing adoptive T cell therapyAbraham Nissani, Shaked Lev-Ari, Tomer Meirson, et al.
Oncoimmunology|May 7, 2020
Immune co-culture cell microarray - a feasible tool for high-throughput functional investigation of lymphocyte-cancer interactionsErez Nissim Baruch, Rona Ortenberg, Camila Avivi, et al.
Anticancer Research|April 1, 2009
Preclinical evaluation of adoptive cell therapy for patients with metastatic renal cell carcinomaGal Markel, Tali Cohen-Sinai, Michal J Besser, et al.
Neurology|August 31, 2023
Incidence and Outcome of Neurologic Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors in Patients With MelanomaJack Pepys, Ronen Stoff, Roni Ramon-Gonen, et al.
Melanoma Research|February 24, 2021
The efficacy of immunotherapy for in-transit metastases of melanoma: an analysis of randomized controlled trialsRoger Olofsson Bagge, Lars Ny, Paolo A Ascierto, et al.
Plos One|March 2, 2013
Nicotinamide inhibits vasculogenic mimicry, an alternative vascularization pathway observed in highly aggressive melanomaOrit Itzhaki, Eyal Greenberg, Bruria Shalmon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 24, 2006
Inhibition of human tumor-infiltrating lymphocyte effector functions by the homophilic carcinoembryonic cell adhesion molecule 1 interactionsGal Markel, Rachel Seidman, Noam Stern, et al.
Molecular Cancer Therapeutics|April 3, 2012
Novel immunotherapy for malignant melanoma with a monoclonal antibody that blocks CEACAM1 homophilic interactionsRona Ortenberg, Yair Sapir, Lee Raz, et al.
Plos One|May 5, 2011
Regulation of cancer aggressive features in melanoma cells by microRNAsEyal Greenberg, Liat Hershkovitz, Orit Itzhaki, et al.
Pageof 16